CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
Sullivan, Kathleen M C, Vilalta, Marta, Ertl, Linda S, Wang, Yu, Dunlap, Carolyn, Ebsworth, Karen, Zhao, Bin N, Li, Shijie, Zeng, Yibin, Miao, Zhenhua, Fan, Pingchen, Mali, Venkat, Lange, Christopher, McMurtrie, Darren, Yang, Ju, Lui, Rebecca, Scamp, Ryan, Chhina, Vicky, Kumamoto, Alice, Yau, Simon, Dang, Ton, Easterday, Ashton, Liu, Shirley, Miao, Shichang, Charo, Israel, Schall, Thomas J, Zhang, Penglie
Published in PloS one (07.06.2023)
Published in PloS one (07.06.2023)
Get full text
Journal Article
A Pilot Screen of a Novel Peptide Hormone Library Identified Candidate GPR83 Ligands
Sallee, Nathan A., Lee, Ernestine, Leffert, Atossa, Ramirez, Silvia, Brace, Arthur D., Halenbeck, Robert, Kavanaugh, W. Michael, Sullivan, Kathleen M. C.
Published in SLAS discovery (01.10.2020)
Published in SLAS discovery (01.10.2020)
Get full text
Journal Article
Inhibition of Nuclear Vesicle Fusion by Antibodies that Block Activation of Inositol 1,4,5-Trisphosphate Receptors
Kathleen M. C. Sullivan, Lin, Doris D., Agnew, William, Wilson, Katherine L.
Published in Proceedings of the National Academy of Sciences - PNAS (12.09.1995)
Published in Proceedings of the National Academy of Sciences - PNAS (12.09.1995)
Get full text
Journal Article